"IMIDAZODIAZEPINES"
Application 201/MAS/1995 published 2005-02-25, filed 1995-02-21
Imidazodiazepines of the general formula wherein A and the two carbon atoms denoted by a and b together signify one of the residues Q signifies one of the residues R1 and R2 each signify hydrogen, lower alkyl, lower alkenyl, lower alkynyl, lower hydroxyalkyl, lower alkoxy-lower alkyl, (C3-C6)-cycloalkyl, (C3-C6)-cycloalkyl-lower alkyl, amino-lower alkyl, lower alkylamino-lower alkyl, di-lower alkylamino-lower alkyl or aryl-lower alkyl or together with the nitrogen atom signify a 5- to 8-membered heterocycle optionally containing a further hetero atom or a fused benzene ring, R3 signifies hydrogen and R4 signifies lower alkyl or R3 and R4 together signify a di- or trimethylene group and R5 and R6 each signify hydrogen, halogen, trifluoromethyl, lower alkoxy or nitro, and the carbon atom denoted by g has the S-configuration when R3 is different from hydrogen, have pronounced anxiolytic, anticonvulsant, muscle relaxant and sedative-hypnotic properties. They form acid addition salts which have very good water solubility and are therefore particularly suitable for the production of aqueous injection solutions.
Applicant
F. HOFFMANN-LA ROCHE AG,
a Swiss Company,, 124, Grenzacherstrasse,, CH-4002, Basle,, SWITZERLAND.
Inventor
International Info
Classification: A61K 31/55
Publication Number:
Priority Information
783/94 SWITZERLAND 1994-03-16
10/1995 SWITZERLAND 1995-01-03